Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124893302 | 12489330 | 2 | F | 20160107 | 20160704 | 20160622 | 20160713 | EXP | JP-CELGENEUS-JPN-2016021728 | CELGENE | 78.24 | YR | M | Y | 0.00000 | 20160713 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124893302 | 12489330 | 1 | PS | VIDAZA | AZACITIDINE | 1 | Subcutaneous | 120 MILLIGRAM | U | 50794 | 120 | MG | INJECTION | ||||||
| 124893302 | 12489330 | 2 | C | Maglax | MAGNESIUM OXIDE | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124893302 | 12489330 | 1 | Product used for unknown indication |
| 124893302 | 12489330 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124893302 | 12489330 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124893302 | 12489330 | Bone marrow failure | |
| 124893302 | 12489330 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124893302 | 12489330 | 1 | 20151222 | 20151227 | 0 | |
| 124893302 | 12489330 | 2 | 20160128 | 0 |